Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Gain Therapeutics, Inc.

1.97
+0.11005.91%
Volume:169.37K
Turnover:334.14K
Market Cap:75.77M
PE:-3.09
High:2.02
Open:1.89
Low:1.89
Close:1.86
52wk High:4.34
52wk Low:1.41
Shares:38.46M
Float Shares:37.12M
Volume Ratio:0.50
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6370
EPS(LYR):-0.8920
ROE:-261.72%
ROA:-86.79%
PB:12.82
PE(LYR):-2.21

Loading ...

OverviewCompanyNewsFilings

Gain Therapeutics Is Maintained at Buy by Maxim Group

Dow Jones
·
Oct 08, 2025

Oppenheimer Remains a Buy on Gain Therapeutics (GANX)

TIPRANKS
·
Oct 07, 2025

Maxim Group Reaffirms Their Buy Rating on Gain Therapeutics (GANX)

TIPRANKS
·
Oct 07, 2025

U.S. RESEARCH ROUNDUP-BlackRock, Goldman Sachs, Netflix

Reuters
·
Oct 07, 2025

Gain Therapeutics Inc : Maxim Group Raises Target Price to $7 From $5

THOMSON REUTERS
·
Oct 07, 2025

Unusually active option classes on open October 6th

TIPRANKS
·
Oct 06, 2025

Gain Therapeutics presents initial data from Phase 1b study of GT-02287

TIPRANKS
·
Oct 06, 2025

Gain Therapeutics Announces Positive Initial Results from Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease Patients

Reuters
·
Oct 06, 2025

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Nov 12, 2025 Pre-Market
Financial Report Announcement
Aug 12, 2025 Pre-Market
Financial Report Announcement
May 14, 2025 Pre-Market
Financial Report Announcement
Mar 27, 2025 Pre-Market
Financial Report Announcement
Nov 14, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.92
Current
-5.35
Sector Average
26.26%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.92
Maximum
-1.06
+1 STD
2.09
Minimum
-48.77
-1 STD
-12.79
Average
-5.35

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.